top
Search terms
Results 1 - 7 of 7 - ordered by :
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 146465 bytes
Ehjournal

Conclusion This analysis highlights the importance of considering the relative severity and multiple events in the evaluation of a clinical trial. See page 869 for the editorial comment on this ...

European Heart Journal, Bakal, Jeffrey A., Westerhout, Cynthia M., Cantor, Warren J., Fernández-Avilés, Francisco, Welsh, Robert C., Fitchett, David, Goodman, Shaun G., Armstrong, Paul W.

Date : 21/03/2013
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 146421 bytes
Ehjournal

Conclusion This analysis highlights the importance of considering the relative severity and multiple events in the evaluation of a clinical trial. See page 869 for the editorial comment on this ...

European Heart Journal, Bakal, Jeffrey A., Westerhout, Cynthia M., Cantor, Warren J., Fernández-Avilés, Francisco, Welsh, Robert C., Fitchett, David, Goodman, Shaun G., Armstrong, Paul W.

Date : 21/03/2013 Item size : 235121 bytes
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 183515 bytes
Ehjournal

Introduction Myocardial infarction (MI) is a widely accepted non-fatal cardiovascular endpoint employed to assess efficacy and/or safety of new treatments in clinical trials. In September 2000, ...

European Heart Journal, Leonardi, Sergio, Armstrong, Paul W., Schulte, Phillip J., Ohman, E. Magnus, Newby, L. Kristin

Date : 21/03/2013 Item size : 645074 bytes
Ehjournal

The costs and complexity of RCTs, including those done in the setting of acute coronary syndromes (ACS), have increased steeply over the past decade, thereby setting a higher standard for the ...

European Heart Journal, Bakal, Jeffrey A., Roe, Matthew T., Ohman, E. Magnus, Goodman, Shaun G., Fox, Keith A.A., Zheng, Yinggan, Westerhout, Cynthia M., Hochman, Judith S., Lokhnygina, Yuliya, ...

Date : 07/02/2015 Item size : 252411 bytes